Expect monthly running costs for a Peptide Therapy Clinic to average near $93,400 in the first year (2026) This figure includes $67,100 in fixed overhead, primarily payroll and the $12,500 premium lease Variable costs, driven by compounded peptide sourcing (85%) and diagnostic lab fees (45%), total 130% of revenue
7 Operational Expenses to Run Peptide Therapy Clinic
#
Operating Expense
Expense Category
Description
Min Monthly Amount
Max Monthly Amount
1
Fixed Wages
Fixed Overhead
The core administrative and management payroll, including the Medical Director and Clinic Manager, totals $47,100 per month in 2026.
$47,100
$47,100
2
Clinic Lease
Fixed Overhead
The fixed monthly expense for the Premium Clinic Lease is $12,500, representing a major component of fixed overhead.
$12,500
$12,500
3
Peptide Sourcing
COGS
This primary Cost of Goods Sold expense is variable, starting at 85% of total treatment revenue in 2026.
$0
$0
4
Lab Fees
Variable Cost
A critical variable cost, Diagnostic Laboratory Fees account for 45% of revenue, decreasing slightly over time due to volume discounts.
$0
$0
5
Liability Insurance
Fixed Overhead
Fixed monthly insurance costs covering malpractice and general liability total $3,200, essential for clinical operations.
$3,200
$3,200
6
Digital Marketing
Variable Cost
This variable operating expense is budgeted at 60% of revenue in 2026, focusing on patient acquisition and brand awareness.
$0
$0
7
Utilities
Fixed Overhead
Facility Utilities & Maintenance is a fixed operating cost estimated at $1,800 per month, covering power, water, and routine upkeep.
$1,800
$1,800
Total
All Operating Expenses
$64,600
$64,600
Peptide Therapy Clinic Financial Model
5-Year Financial Projections
100% Editable
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Accounting Or Financial Knowledge
What is the total monthly running budget needed for the first 12 months of operation?
The total monthly running budget for the Peptide Therapy Clinic starts with $67,100 in fixed overhead, but the real issue is the 215% variable cost ratio, meaning you lose money on every sale; you can find more detail on structuring this early stage financial plan here: How To Write A Business Plan For Peptide Therapy Clinic?
Fixed Monthly Overhead
Fixed costs hit $67,100 monthly.
This covers lease and admin payroll.
Insurance costs are also included here.
This is your minimum cash floor.
Variable Cost Drag
Variable costs equal 215% of revenue.
You lose 115% on every transaction.
Revenue actively increases monthly losses.
Revisit pricing or supply chain costs now.
Which cost categories represent the largest recurring monthly expenses?
The largest recurring costs for the Peptide Therapy Clinic are fixed payroll at $47,100 monthly and the clinic lease at $12,500, but the biggest drain is the variable cost of peptide sourcing, which eats up 85% of revenue. If you're looking at upfront costs before scaling, check out the breakdown for How Much To Start Peptide Therapy Clinic Business? You'll defintely need to manage that COGS line item aggressively.
Fixed Overhead Anchors
Payroll drives fixed costs at $47,100 monthly.
The premium clinic lease adds $12,500 fixed expense.
Total fixed overhead hits $59,600 monthly.
This amount must be covered regardless of volume.
The Variable Cost Squeeze
Peptide sourcing is the primary cost lever.
This material cost consumes 85% of total revenue.
It dwarfs fixed costs when revenue is high.
Focus on supplier negotiation to cut this rate.
How much working capital or cash buffer is required to sustain operations before profitability?
You need a minimum cash buffer of $746,000 secured by June 2026 to cover initial capital expenditures and the operational ramp-up phase for your Peptide Therapy Clinic, even if monthly operations hit break-even quickly; you'll defintely need this runway. For a deeper dive into the initial setup costs driving this need, check out How Much To Start Peptide Therapy Clinic Business?
Cash Buffer Needs
The minimum required cash reserve stands at $746,000.
This figure accounts for initial Capital Expenditures (CapEx).
It funds the operational runway until patient volume stabilizes.
Revenue scales based on practitioner capacity and treatment pricing.
Ramp-Up Reality
Early break-even doesn't eliminate the need for upfront capital.
The fee-for-service model demands cash for patient acquisition.
Target market is affluent individuals aged 35 to 65.
Physician-led, data-driven methods support premium service pricing.
How will the clinic cover running costs if patient volume or revenue is lower than expected?
Covering the $67,100 in fixed costs requires selling at least 79 treatments monthly, leveraging that high $850 average price point; you can check industry earnings data to see if that volume is realistic: How Much Does A Peptide Therapy Clinic Owner Make?
Break-Even Volume Threshold
Monthly fixed overhead sits at $67,100.
Required treatments: $67,100 divided by $850 average price.
This means you need 79 patient visits monthly just to break even.
If volume drops to 60 visits, you face a $14,900 operating deficit.
Leveraging High Price Points
The $850 average price per Medical Doctor treatment is your main lever.
Focus sales efforts on high-value, personalized protocols first.
Low volume means variable costs are low, but fixed costs defintely dominate.
If client onboarding takes 14+ days, the risk of early churn increases sharply.
Peptide Therapy Clinic Business Plan
30+ Business Plan Pages
Investor/Bank Ready
Pre-Written Business Plan
Customizable in Minutes
Immediate Access
Key Takeaways
The average monthly running cost for a Peptide Therapy Clinic in its first year is projected to be approximately $93,400.
Fixed overhead expenses, primarily driven by administrative payroll ($47,100) and the premium lease ($12,500), total $67,100 monthly.
Despite high variable costs, the financial model projects rapid stability, achieving operational break-even within just one month of opening.
A minimum cash buffer of $746,000 is required upfront to cover initial capital expenditures and sustain operations during the ramp-up phase.
Running Cost 1
: Fixed Administrative Wages
Admin Payroll Load
Fixed administrative wages are a substantial, predictable drain on monthly cash flow. For 2026 projections, the combined payroll for the Medical Director and Clinic Manager sets a floor cost of $47,100 per month. This fixed expense must be covered regardless of patient volume. You need high utilization just to cover this baseline.
Fixed Staff Cost Drivers
This $47,100 covers essential, non-revenue-generating leadership roles needed for compliance and operations. It's a fixed overhead component, unlike variable costs like peptide sourcing (85% of revenue). You need to model this cost against projected patient volume to determine the minimum required monthly revenue just to break even on salaries.
Includes Medical Director salary.
Includes Clinic Manager salary.
Fixed at $47,100 monthly for 2026.
Managing Fixed Salaries
Controlling this cost means optimizing staffing efficiency, not just cutting salaries. If the Medical Director handles too few patient consults, that fixed spend is inefficient. Consider staggered start dates or performance-based bonuses tied to clinic throughput to align incentives. Defintely avoid overstaffing early on.
Tie management bonuses to utilization.
Stagger hiring start dates.
Ensure Medical Director capacity is high.
Break-Even Impact
When combined with the $12,500 clinic lease and $3,200 insurance, administrative wages form the bulk of your non-variable overhead. This $47,100 salary base means your clinic must generate substantial revenue just to pay management before accounting for variable costs like sourcing (85%) and labs (45%).
Running Cost 2
: Premium Clinic Lease
Lease Impact
Your clinic lease costs $12,500 monthly, which is a significant, non-negotiable fixed cost. This expense hits your bottom line before you treat a single client. You need enough patient volume just to cover this rent plus other overheads like wages to stay afloat.
Cost Breakdown
This $12,500 covers the premium space needed for physician-led services. It's a core fixed overhead, sitting alongside $47,100 in administrative wages and $3,200 for liability insurance. Honestly, these fixed costs set your minimum revenue hurdle for the month.
Lease: $12,500 fixed monthly.
Total fixed overhead starts high.
Need volume to absorb rent quickly.
Manage Fixed Rent
You can't easily cut this once signed, so diligence upfront is key. Avoid locking into long terms if patient volume projections are uncertain; that's a defintely risky move. Look for favorable tenant improvement allowances to reduce initial build-out capital required.
Negotiate tenant improvement funds.
Watch renewal escalation clauses.
Ensure zoning fits service needs.
Fixed Burden
Because the lease is fixed, every new patient visit after covering overhead directly improves margin. If your total fixed costs are around $62,800 (including wages and insurance), you must generate significant variable revenue just to break even before profit shows up.
Running Cost 3
: Compounded Peptide Sourcing
Peptide COGS Shock
Peptide sourcing is your largest variable cost, hitting 85% of treatment revenue right out of the gate in 2026. This high percentage means gross margin is defintely tight, putting immense pressure on controlling patient acquisition costs. Managing this single line item dictates near-term profitability.
Sourcing Cost Inputs
This cost covers the actual compounded peptides used in patient treatments. To estimate it precisely, you need the projected number of treatments multiplied by the specific cost per compound dose. Since it's 85% of revenue, every dollar earned immediately translates to 85 cents in peptide expense.
Covers raw peptide materials.
Input: Doses needed × unit cost.
Sets initial gross margin at 15%.
Sourcing Cost Control
Reducing an 85% COGS requires deep supply chain work, not just minor negotiation. Focus on volume commitments early, even if initial patient volume is low. Avoid stocking excessive inventory, which ties up cash and risks expiration. Secure multi-year sourcing contracts for stability.
Negotiate tiered pricing based on volume.
Standardize common compound libraries.
Avoid over-ordering inventory upfront.
The Margin Squeeze
Because sourcing is 85% of revenue, your other variable costs-like Diagnostic Lab Fees (45%) and Marketing (60%)-are impossible to cover unless you significantly raise prices or drastically cut sourcing costs. This structure is unsustainable without volume leverage.
Running Cost 4
: Diagnostic Laboratory Fees
Lab Fees Impact
Diagnostic Laboratory Fees are a major variable cost hitting 45% of revenue right at launch in 2026. These costs drop slightly as patient volume grows, thanks to expected volume discounts. This expense directly ties to every personalized treatment protocol you sell.
Cost Inputs
These fees cover the external testing required for personalized peptide protocols, like comprehensive biomarker analysis. To model this accurately, you must track projected monthly revenue and apply the initial 45% rate. This cost is defintely separate from the 85% spent on Compounded Peptide Sourcing.
Managing Lab Spend
Since the rate drops with scale, negotiating tiered pricing with your selected lab partners is key. Aim to hit the next discount bracket quickly. Watch out for scope creep; ensure testing panels only include necessary biomarkers, not optional add-ons that inflate the per-test cost.
Margin Pressure
With Diagnostic Laboratory Fees at 45% and Digital Marketing at 60% of revenue, your gross margin structure is extremely thin before accounting for fixed overhead like the $47,100 in administrative wages. Pricing must aggressively cover these variable burdens to ensure profitability on each client engagement.
Running Cost 5
: Malpractice and Liability Insurance
Essential Fixed Insurance
Fixed insurance costs for clinical operations total $3,200 per month. This covers both malpractice and general liability protection, which is absolutely essential before you treat any client. Don't confuse this necessary fixed overhead with variable patient acquisition spending. This cost is locked in regardless of patient volume.
Budgeting Clinical Coverage
This $3,200 is a fixed monthly commitment for clinical operation safety. It protects against claims arising from professional services rendered, like peptide administration protocols. You must budget this amount immediately; it's a prerequisite for running any medical service here in the US.
Covers professional negligence claims.
Fixed cost, not tied to revenue.
Budget $38,400 annually upfront.
Managing Premium Spend
Managing this cost means ensuring you aren't over-insured for your specific risk profile. Shop quotes from specialized medical brokers, not generalists. A clean claims history helps negotiate better renewal rates next year when your volume increases.
Shop quotes every renewal cycle.
Ensure limits match risk exposure.
Don't accept automatic renewals blindly.
Scaling Policy Checks
Scaling operations by adding more practitioners or expanding service lines requires immediate policy review. Premiums adjust based on physician count and treatment complexity. If coverage lapses, clinical activity must stop defintely.
Running Cost 6
: Digital Marketing & Acquisition
Acquisition Budget Scale
In 2026, patient acquisition spending is set aggressively high at 60% of total revenue to build brand awareness among affluent clients. This high variable cost means every dollar spent must drive high-value, recurring patient visits to justify the budget.
Cost Inputs
This expense covers digital outreach and brand building aimed at attracting affluent patients aged 35 to 65. Since it is budgeted at 60% of revenue in 2026, if monthly revenue hits $200,000, acquisition spending is $120,000. You must track Cost Per Acquisition (CPA) rigorously.
Focus on high-intent search terms.
Measure patient conversion rates precisely.
Link spend directly to practitioner capacity.
Managing Spend
With 60% of revenue allocated here, retention is critical to avoid burning cash quickly. The goal isn't just getting the first visit, but securing repeat treatments. If onboarding takes 14+ days, churn risk rises defintely.
Fixed overhead sits near $64,600 monthly before marketing. If revenue lags, spending 60% of revenue on acquisition accelerates losses. You need high patient volume quickly to cover fixed costs before this variable spend overwhelms cash flow.
Running Cost 7
: Utilities and Maintenance
Fixed Utility Burn
Facility Utilities & Maintenance is a fixed operating expense set at $1,800 per month for the clinic. This figure covers essential services like power, water, and standard upkeep necessary for clinical operations. It's a predictable, non-negotiable monthly burn rate you must cover regardless of patient flow.
Cost Inputs
This $1,800 monthly figure is fixed overhead, not tied to treatment revenue. It bundles essential facility costs like electricity, water usage, and scheduled preventative maintenance. Compared to the $47,100 in administrative wages, this cost is small but must be budgeted consistently to keep the lights on.
Covers power and water bills.
Includes routine upkeep schedules.
Fixed component of overhead.
Managing Upkeep
Since this cost is fixed, savings come from efficiency, not volume cuts. Focus on energy efficiency upgrades in the clinic space, especially HVAC, which often drives utility spikes. Avoid deferring maintenance; small repairs prevent huge, unexpected capital expenditures later on. We defintely need to track these items monthly.
Audit HVAC efficiency annually.
Negotiate fixed-rate utility contracts.
Ensure service contracts are competitive.
Overhead Context
While $1,800 seems minor next to the $12,500 clinic lease payment, these small fixed costs accumulate fast. If you add in the $3,200 insurance, these non-volume-dependent expenses eat into contribution margin before the first peptide is even compounded. It's a constant drag on profitability.
Monthly running costs average $93,400 in Year 1, covering $67,100 in fixed overhead and variable costs like peptide sourcing (85% of revenue) and lab fees (45%)
The financial model projects a break-even date in January 2026, meaning the clinic achieves profitability within 1 month of operation, with a full payback period of 13 months
About the author
Jonathan Bell
First-Time Founder Guide Writer
Jonathan Bell is a Financial Models Lab writer focused on launch budget planning, helping aspiring small business owners estimate startup needs before opening. As a first-time founder guide writer, he explains business costs in simple language and offers simple launch planning insights that help readers compare business opportunities realistically and make grounded real-world decisions.
Choosing a selection results in a full page refresh.
